Comparison of radiorespirometric budemeyer assay with ATP assay and mouse foot pad test in detecting viable Mycobacterium leprae from clinical samples

Indian Journal of Medical Microbiology

Volumn 25, Issue 4, 2007, Pages 358-363

  Agrawal, V ^a   Shetty, V ^a  

^a FOUNDATION FOR MEDICAL RESEARCH   (India)

Author keywords

Adenosine triphosphate assay; M. leprae; Mouse foot pad test; Radiorespirometric Buddemeyer assay; Viability

Indexed keywords

ANALYTIC METHOD; ARTICLE; ASSAY; BACTERIAL VIABILITY; BACTERIUM DETECTION; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LEPROMATOUS LEPROSY; MAJOR CLINICAL STUDY; MOUSE FOOT PAD TEST; MYCOBACTERIUM LEPRAE; NONHUMAN; RADIORESPIROMETRIC BUDDEMEYER ASSAY WITH ATP ASSAY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SKIN BIOPSY; TUBERCULOID LEPROSY; VALIDATION PROCESS;

EID: 37549038219     PISSN: 02550857     EISSN: 02550857     Source Type: Journal    
DOI: 10.4103/0255-0857.37339     Document Type: Article

References (23)

1. Shephard CC. The experimental disease that follows the infections of human leprosy bacilli into the foot pads of mice. J Exp Med 1960;112:445-54.
2. Shepard CC. A survey of drugs with activity against M. leprae. Int J Lepr Other Mycobact Dis 1971;39:340-8.
3. Desikan KV. Correlation of morphology with viability of Mycobacterium leprae. Lepr India 1976;48:391-7.
4. In vitro methods for rapid monitoring of drug therapy and drug resistance in leprosy. ICMR Bull 2001;31:73-84.
5. Dhople AM. Adenosine triphosphate content of Mycobacterium leprae from leprosy patients. Int J Lepr Other Mycobact Dis 1984;52:183- 8.
6. Gupta UD, Katoch K, Sharma RK, Singh HB, Natragan M, Singh D, et al. Analysis of quantitative relationship between viability determination in leprosy by MFP, ATP bioluminescence and gene amplification assay. Int J Lepr Other Mycobact Dis 2001;69:328-34.
7. Jagannathan R, Mahadevan PR. Concurrence of the in vitro methods of Fc receptor assay and ATP estimation for viability of Mycobacterium leprae. Med Sci Res 1987;15:1377-8.
8. Katoch VM, Katoch K, Ramu G, Sharma VD, Datta AK, Shivannavar CT, et al. In vitro methods for determination of viability of mycobacteria: Comparison of ATP content, morphological index and FDA-EB fluorescent staining in Mycobacteria leprae. Lepr Rev 1988;59:137-43.
9. Franzblau SG. Oxidation of palmitic acid by Mycobacterium leprae in an axenic medium. J Clin Microbiol 1988;26:18-21.
10. Truman RW, Krahenuhl JL. Viable M. leprae as a research reagent. Int J lepr Other Mycobact Dis 2001;69:1-12.
11. Franzblau SG, Biswas AN, Jenner P, Colston MJ. Double-blind evaluation of BACTEC and Buddemeyer-type radiorespirometric assays for in vitro screening of antileprosy agents. Lepr Rev 1992;63:125-33.
12. Chan GP, Garcia-Ignacio BY, Chavez VE, Livelo JB, Jimenez CL, Parilla ML, et al. Clinical trial of clarithromycin for lepromatous leprosy. Antimicrob Agents Chemother 1994;38:515-7.
13. Agrawal VP & Shetty, VP. Comparison of the mouse foot pad test with a Buddemeyer type radiorespirometric assay in detecting viable Mycobacterium leprae in human lesional biopsies. Ind J Dermatol Venereol Leprol 2007;73:384-8.
14. Ridley DS, Jopling WH. Classification of leprosy according to immunity: A five group system. Int J Lepr Other Mycobact Dis 1966;34:255-73.
15. World Health Organization. Laboratory techniques for leprosy. WHO/CDS/LEP/86.4. World Health Organization: Geneva; 1987.
16. Buddemeyer E, Hutchinson R, Cooper M. Automatic quantitative radiometric assay of bacterial metabolism. Clin Chem 1976;22:4159-64.
17. Gupta UD, Katoch K, Singh HB, Natrajan M, Sharma VD, Katoch VM. Detection of viable organisms in leprosy patients treated with MDT. Acta Leprol 1999;11:89-92.
18. Chae GT, Kim MJ, Kang TJ, Lee SB, Shin HK, Kim JP, et al. DNA-PCR and RNA-PCR for the 18-kDa gene of Mycobacterium leprae to assess the efficacy of multi-drug therapy for leprosy. J Med Microbiol 2002;51:417-22.
19. Ebenezer GJ, Daniel S, Norman G, Daniel E, Job CK. Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy? Indian J Lepr 2004;76:199-206.
20. Shetty VP, Suchitra K, Uplekar MW, Antia NH. Higher incidence of viable Mycobacterium leprae with in nerve as compared to skin among multibacillary leprosy patients released from multidrug therapy. Lepr Rev 1997;68:131-8.
21. Shetty VP, Suchitra K, Uplekar MW, Antia NH. Persistence of Mycobacterium leprae in the peripheral nerve as compared to the skin of multidrug-treated leprosy patients. Lepr Rev 1992;63:329-36.
22. Shah DH, Deodhar MN, Ganatra RD, Narkar AA, Buddemeyer EU. A rapid radiometric method for detection of M. tuberculosis: Optimization of experimental conditions. Int J Nucl Med Biol 1984;11:283-6.
23. Shah DH, Devdhar MN, Ganatra RD, Kale PN, Virdi SS, Deshmukh MD. Modified rapid radiometric method for detection of Mycobacterium tuberculosis from sputum samples. Int J Nucl Med Biol 1985;12:333-5.